Generic name: |
icatibant |
|
---|---|---|
Strength: |
30 mg/3 mL |
|
Form: |
pre-filled syringe |
Special Authority criteria |
Approval period |
---|---|
Initial: For the treatment of acute attacks of hereditary angioedema (HAE) in adult patients with lab confirmed c1-esterase inhibitor deficiency (type I or type II) who meet ALL of the following criteria:
AND
AND
|
1 year1 |
Renewal:
AND
AND
|
1 year1 |